Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 5, 2001, Pages 462-469

  Eberhart, Charles G ^a,c   Kaufman, Walter E ^a,b   Tihan, Tarik ^a   Burger, Peter C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Apoptosis; Desmoplastic; Medulloblastoma; Neurotrophin; Nodular; PNET; Trk

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR; PROTEIN BCL 2; PROTEIN P53; SYNAPTOPHYSIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEDULLOBLASTOMA; MOLECULAR WEIGHT; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROFILAMENT; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0035006794     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.5.462     Document Type: Article

References (46)

1. Burger PC, Grahmann FC, Bliestle A, Kleihues P. Differentiation in the medulloblastoma: A histologic and immunohistochemical study. Acta Neuropathol 1987;73:115-23
2. Herpers MJHM, Budka H. Primitive neuroectodermal tumors including the medulloblastoma: Glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum"). Clin Neuropathol 1985;4:12-18
3. Kleihues P, Cavenee WK. Tumors of the nervous system. Lyon, France: IARC press, 2000
4. Katsetos CD, Herman MM, Frankfurter A, et al. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands. Arch Pathol Lab Med 1989;113:1019-29
5. Katsetos CD, Liu HM, Zack SL. Immunohistochemical and ultrastructural observations on Homer Wright (neuroblastic) rosettes and the "pale islands" of human cerebellar medulloblastomas. Hum Pathol 1988;19:1219-27
6. Chatty EM, Earle KM. Medulloblastoma. A report of 201 cases with an emphasis on the relationship of histologic variants to survival. Cancer 1971;28:977-83
7. Bailey CC, Gnekow A, Wellek S, et al. Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Pediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO): SIOP II. Med Ped Onc 1995;25:166-78
8. Jenkin D, Shabanah MA, Shail EA, et al. Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys 2000;47:573-84
9. Sure U, Berghorn WJ, Bertalanffy H, et al. Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institution. Acta Neurochir (Wien) 1995;132:59-65
10. Giangaspero F, Rigobello L, Badiali M, et al. Medulloblastoma with extensive modularity: A variant with favorable prognosis. J Neurosurg 1999;91:971-77
11. Pietsch T, Waha A, Koch A, et al. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997;57:2085-88
12. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. PNAS 1994;91:12867-71
13. Grotzer MA, Janss AJ, Fung KM, et al. TrkC expression predicts good clinical outcomes in primitive neuroectodermal brain tumors. J Clin Oncol 2000;18:1027-35
14. Kim JY, Sutton ME, Lu DJ, et al. Activation of neurotrophin receptor TrkC induces apoptosis in medulloblastomas. Cancer Res 1999;59:711-19
15. Kaplan DR, Miller FD. Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 1997;9:213-21
16. Chou TT, Trojanowski JQ, Lee VMY. Neurotrophin signal transduction in medulloblastoma. J Neurosci Res 1997;49:522-27
17. Pomeroy SL, Sutton ME, Goumnerova LC, Segal RA. Neurotrophins in cerebellar granule cell development and medulloblastoma. J Neurooncol 1997;35:347-52
18. Kaufmann WE, MacDonald SM, Altamura CR. Dendritic cytoskeletal protein expression in mental retardation: An immunohistochemical study of the neocortex in Rett syndrome. Cereb Cortex 2000;10:992-1004
19. Stevenson L, Echlin F. Nature and origin of some tumors of the cerebellum. Medulloblastoma. Arch Neurol Psychiat 1934;31:93-109
20. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997;277:1109-13
21. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nature Med 1998;4:619-22
22. Altman J. Postnatal development of the cerebellar cortex in the rat. J Comp Neurol 1972;145:353-98
23. Lossi L, Zagzag D, Greco MA, Merighi A. Apoptosis of undifferentiated progenitors and granule cell precursors in the postnatal human cerebellar cortex correlates with expression of BCL-2, ICE, and CPP32 proteins. J Comp Neurol 1998;399:359-72
24. Sarnat HB, Nochlin D, Born DE. Neuronal nuclear antigen (NeuN): A marker of neuronal maturation in early human fetal nervous system. Brain Dev 1998;20:88-94
25. Sarnat HB, Born DE. Synaptophysin immunocytochemistry with thermal intensification: A marker of terminal axonal maturation in the human fetal nervous system. Brain Dev 1999;21:41-50
26. Kaufmann WE, Taylor CV, Lishaa NA. Immunoblotting patterns of cytoskeletal dendridic protein expression in human neocortex. Mol Chem Neuropathol 1997;31:235-44
27. Schubert TE, Cervos-Navarro J. The histopathological and clinical relevance of apoptotic cell death in medulloblastomas. J Neuropathol Exp Neurol 1998;57:10-15
28. Schiffer D, Cavalla P, Chio A, et al. Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 1994;87:362-70
29. Haslam RH, Lamborn KR, Becker LE, Israel MA. Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma. J Ped Hem One 1998;20:520-27
30. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat. BCL-2 distribution in neuroepithelial tumors: An immunohistochemical study. J Neurooncol 1996;27:101-9
31. Bernier PJ, Vinet J, Cossette M, Parent A. Characterization of the subventricular zone of the adult human brain: Evidence for the involvement of Bcl-2. Neuroscience Res 2000;37:67-78
32. Vakrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J. Bax promotes neuronal cell death and is downregulated during development of the nervous system. Development 1997;124:1239-49
33. Tanabe H, Eguchi Y, Kamada S, Martinou JC, Tsujimoto Y. Susceptibility of cerebellar granule neurons derived from Bcl-2 deficient and transgenic mice to cell death. Eur J Neurosci 1997;9:848-56
34. Ohgaki H, Eibl RH, Schwab M, et al. Mutations in the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 1993;8:74-80
35. Adesina AM, Nalbantoglu J, Cavenee WK. P53 mutation and mdm2 gene amplification are uncommon in medulloblastoma. Cancer Res 1994;54:5649-51
36. Karamitopoulou E, Perentes E, Diamantis I. P53 protein expression in central nervous system tumors: An immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropath 1993;85:611-16
37. Campagne MVL, Gill R. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: Comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p16Ink4a, Cyclin G1, and the protooncogene Bax. J Comp Neurol 1998;397:181-98
38. Anderson KD, Alderson RF, Altar CA, et al. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. J Comp Neurol 1995;357:296-317
39. Washiyama K, Muragaki Y, Rorke LB, et al. Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. Am J Pathol 1996;148:929-40
40. Tajima Y, et al. Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors. Acta Neuropath. 1998;95:325-32
41. Chiappa SA, Chin LS, Zurawel RH, Raffel C. Neurotrophin and Trk receptors in primitive neuroectodermal tumor cell lines. Neurosurgery 1999;45:1148-55
42. Pomeroy SL, Sutton ME, Goumnerova LC, Segal RA. Neurotrophins in cerebellar granule cell development and medulloblastoma. J Neurooncol 1997;35:347-52
43. Neveu I, Arenas E. Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo. J Cell Biol 1996;133:631-46
44. Buhren J, Christoph AHA, Buslei R, Albrecht S, Wiestler OD, Pietsch T. Expression of the neurotrophin receptor p75ntr in medulloblastomas is correlated with distinct histological and clinical features: Evidence for a medulloblastoma subtype derived from the external granule cell layer. J Neuropathol Exp Neurol 2000;59:229-40
45. Adesina AM, Dunn ST, Moore WE, Nalbantoglu J. Expression of p27kip1 and p53 in medulloblastoma: Relationship with cell proliferation and survival. Path Res Practice 2000;196:243-50
46. Schiffer D, Bortolotto S, Bosone L, et al. Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors. Neurosci Lett 1999;264:29-32